BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26358750)

  • 1. HMDB and 5-AzadC Combination Reverses Tumor Suppressor CCAAT/Enhancer-Binding Protein Delta to Strengthen the Death of Liver Cancer Cells.
    Li CF; Tsai HH; Ko CY; Pan YC; Yen CJ; Lai HY; Yuh CH; Wu WC; Wang JM
    Mol Cancer Ther; 2015 Nov; 14(11):2623-33. PubMed ID: 26358750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CEBPD reverses RB/E2F1-mediated gene repression and participates in HMDB-induced apoptosis of cancer cells.
    Pan YC; Li CF; Ko CY; Pan MH; Chen PJ; Tseng JT; Wu WC; Chang WC; Huang AM; Sterneck E; Wang JM
    Clin Cancer Res; 2010 Dec; 16(23):5770-80. PubMed ID: 20971808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin promotes apoptosis in hepatocellular carcinoma through the CEBPD-induced autophagy pathway.
    Tsai HH; Lai HY; Chen YC; Li CF; Huang HS; Liu HS; Tsai YS; Wang JM
    Oncotarget; 2017 Feb; 8(8):13832-13845. PubMed ID: 28099155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ROCK2 promotes HCC proliferation by CEBPD inhibition through phospho-GSK3β/β-catenin signaling.
    Li M; Zhou W; Yuan R; Chen L; Liu T; Huang D; Hao L; Xie Y; Shao J
    FEBS Lett; 2015 Apr; 589(9):1018-25. PubMed ID: 25771860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sorafenib enhances the chemotherapeutic efficacy of S-1 against hepatocellular carcinoma through downregulation of transcription factor E2F-1.
    Zhai JM; Yin XY; Lai YR; Hou X; Cai JP; Hao XY; Liang LJ; Zhang LJ
    Cancer Chemother Pharmacol; 2013 May; 71(5):1255-64. PubMed ID: 23435877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Aza-2<-deoxycytidine induces hepatoma cell apoptosis via enhancing methionine adenosyltransferase 1A expression and inducing S-adenosylmethionine production.
    Liu WJ; Ren JG; Li T; Yu GZ; Zhang J; Li CS; Liu ZS; Liu QY
    Asian Pac J Cancer Prev; 2013; 14(11):6433-8. PubMed ID: 24377546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of the prodrugs perforin-CEBPD and perforin-granzyme B efficiently enhances the activation of caspase signaling and kills prostate cancer.
    Chuang CH; Wang WJ; Li CF; Ko CY; Chou YH; Chuu CP; Cheng TL; Wang JM
    Cell Death Dis; 2014 May; 5(5):e1220. PubMed ID: 24810056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action and clinical significance of CCAAT/enhancer-binding protein delta in hepatocellular carcinoma.
    Liu P; Cao W; Ma B; Li M; Chen K; Sideras K; Duitman JW; Sprengers D; Khe Tran TC; Ijzermans JNM; Biermann K; Verheij J; Spek CA; Kwekkeboom J; Pan Q; Peppelenbosch MP
    Carcinogenesis; 2019 Mar; 40(1):155-163. PubMed ID: 30325409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
    Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z
    Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.
    Chen MC; Huang HH; Lai CY; Lin YJ; Liou JP; Lai MJ; Li YH; Teng CM; Yang CR
    Oncotarget; 2016 Jan; 7(1):402-17. PubMed ID: 26587975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Water extract of Hedyotis Diffusa Willd suppresses proliferation of human HepG2 cells and potentiates the anticancer efficacy of low-dose 5-fluorouracil by inhibiting the CDK2-E2F1 pathway.
    Chen XZ; Cao ZY; Chen TS; Zhang YQ; Liu ZZ; Su YT; Liao LM; Du J
    Oncol Rep; 2012 Aug; 28(2):742-8. PubMed ID: 22641337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells.
    Chan DW; Lee JM; Chan PC; Ng IO
    Int J Cancer; 2008 Sep; 123(5):1043-52. PubMed ID: 18553387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
    Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M
    Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the microRNA-21/AP1 axis by 5-fluorouracil and pirarubicin in human hepatocellular carcinoma.
    He X; Li J; Guo W; Liu W; Yu J; Song W; Dong L; Wang F; Yu S; Zheng Y; Chen S; Kong Y; Liu C
    Oncotarget; 2015 Feb; 6(4):2302-14. PubMed ID: 25544773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression.
    Yang J; Jin X; Yan Y; Shao Y; Pan Y; Roberts LR; Zhang J; Huang H; Jiang J
    Sci Rep; 2017 Mar; 7():43864. PubMed ID: 28262837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-aza-2'-deoxycytidine has minor effects on differentiation in human thyroid cancer cell lines, but modulates genes that are involved in adaptation in vitro.
    Dom G; Galdo VC; Tarabichi M; Tomás G; Hébrant A; Andry G; De Martelar V; Libert F; Leteurtre E; Dumont JE; Maenhaut C; van Staveren WC
    Thyroid; 2013 Mar; 23(3):317-28. PubMed ID: 23167291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
    Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
    Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of MEK suppresses hepatocellular carcinoma growth through independent MYC and BIM regulation.
    Zhou X; Zhu A; Gu X; Xie G
    Cell Oncol (Dordr); 2019 Jun; 42(3):369-380. PubMed ID: 30788663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistically killing activity of aspirin and histone deacetylase inhibitor valproic acid (VPA) on hepatocellular cancer cells.
    Li X; Zhu Y; He H; Lou L; Ye W; Chen Y; Wang J
    Biochem Biophys Res Commun; 2013 Jun; 436(2):259-64. PubMed ID: 23726914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.